BOURAS, S. (2025). Management of c/pT3a Renal Cell Carcinoma in Light of EAU Guidelines. , 31(1), 44-54. doi: 10.33762/basjsurg.2025.157310.1106
Samir BOURAS. "Management of c/pT3a Renal Cell Carcinoma in Light of EAU Guidelines". , 31, 1, 2025, 44-54. doi: 10.33762/basjsurg.2025.157310.1106
BOURAS, S. (2025). 'Management of c/pT3a Renal Cell Carcinoma in Light of EAU Guidelines', , 31(1), pp. 44-54. doi: 10.33762/basjsurg.2025.157310.1106
BOURAS, S. Management of c/pT3a Renal Cell Carcinoma in Light of EAU Guidelines. , 2025; 31(1): 44-54. doi: 10.33762/basjsurg.2025.157310.1106

Management of c/pT3a Renal Cell Carcinoma in Light of EAU Guidelines

Basrah Journal of Surgery
Volume 31, Issue 1, 2025, Pages 44-54    PDF (955.05 K)
Document Type: Review Paper
DOI: 10.33762/basjsurg.2025.157310.1106
Author
Samir BOURAS*
Associate Professor. Department of Urology Ferhat Abbas University Setif Algeria
Abstract
Introduction: The diagnosis and management of cT3a renal cell carcinoma with perirenal fat invasion (cT3a-PFI) remain complex due to the lack of standardized imaging protocols and the ambiguity in surgical decision-making. The aim of this review is to analyze this management approach primarily through European and French guidelines.
Methods: A literature search was conducted using PubMed, with keywords including "Renal cell carcinoma," "cT3a," "pT3a," and "perirenal fat invasion." Studies published in English between 2000 and 2024 were included. After screening, 42 articles were selected based on relevance, study design, and level of evidence.
Results: Studies report better recurrence-free survival (RFS) and cancer-specific survival (CSS) for cT3a-PFI compared to sinus or vascular invasion. However, preoperative diagnosis remains challenging, with imaging features such as tumor contour irregularity showing low specificity for tumors >4 cm. Partial nephrectomy (PN) offers comparable oncological outcomes to radical nephrectomy (RN) for tumors ≤7 cm, while RN is preferred for larger tumors due to technical complexity and risk of positive margins. The favorable prognosis of cT3a-PFI ≤4 cm suggests these tumors may warrant reclassification within the TNM staging system.
Discussion: The retrospective nature of most studies introduces selection bias, limiting the robustness of findings. Despite advancements, the lack of standardized diagnostic criteria remains a major barrier. Future research should refine surgical guidelines and explore advanced techniques such as radiomics and artificial intelligence.
Conclusion: An individualized surgical approach tailored to tumor size and technical feasibility remains key to optimizing outcomes in cT3a-PFI RCC. Prospective studies are needed to address limitations and improve management.
Keywords
RCC; c/pT3a staging; Perirenal fat invasion; Surgery; Oncological outcomes
Supplementary Files
References
  1. Rini BI, McKiernan JM, Chang SS, et al. Kidney. In: Amin MB, editor. AJCC cancer staging manual. 8th ed. New York: Springer; 2017. p. 739.
  2. Ljungberg B, Bex A, Albiges L, Bedke J, Capitanio U, Dabestani S, et al. EAU Guidelines on Renal Cell Carcinoma 2024. Renal Cell Carcinoma - Uroweb EAU-Guidelines-on-Renal-Cell-Carcinoma-2024.pdf
  3. Ng CS, Wood CG, Silverman PM, Tannir NM, Tamboli P, Sandler CM. Renal cell carcinoma: Diagnosis, staging, and surveillance. AJR Am J Roentgenol 191: 1220-1232, 2008.
    https://doi.org/10.2214/AJR.07.3568
  4. Lama JS, Klatte T, Patard JJ, Goel RH, Guille F, Lobel B, et al. Prognostic relevance of tumour size in T3a renal cell carcinoma: A multicentre experience. Eur Urol. 2007;52(1):155-162. https://doi.org/10.1016/j.eururo.2007.01.106
  5. Renard AS, Nedelcu C, Paisant A, Saulnier P, Le Bigot J, Azzouzi AR, et al. Is multidetector CT-scan able to detect T3a renal tumor before surgery? Scand J Urol. 2019 Oct;53(5):350-355
    https://doi.org/10.1080/21681805.2019.1675756
  6. Park M, Shim M, Kim M, Song C, Kim C-S, Ahn H et al. Prognostic heterogeneity in T3aN0M0 renal cell carcinoma according to the site of invasion. Urol Oncol. 2017;35(7):458.e17-458.e22. https://doi.org/10.1016/j.urolonc.2016.05.019
  7. Thompson RH, Leibovich BC, Cheville JC, et al. Is renal sinus fat invasion the same as perinephric fat invasion for pT3a renal cell carcinoma? J Urol 2005;174:1218-21.
    https://doi.org/10.1097/01.ju.0000173942.19990.40
  8. Stout TE, Gellhaus PT, Tracy CR, Steinberg RL. Robotic partial vs radical nephrectomy for clinical T3a tumors: A narrative review. J Endourol. 2023;37(9):978-985.
    https://doi.org/10.1089/end.2023.0173
  9. Xu P, Zhang S, Cao B, Li Y, Huang J, Lin W, et al. Predictive value of renal tumor contour irregularity score in pathological T3a upstaging of clinical T1 renal cell carcinoma: A multi-institutional study. Urol Oncol. 2022;40(5):199.e1-199.e8.
    https://doi.org/10.1016/j.urolonc.2022.02.005
  10. Landman J, Park JY, Zhao C, Baker M, Hofmann M, Helmy M, et al. Preoperative computed tomography assessment for perinephric fat invasion: Comparison with pathological staging. J Comput Assist Tomogr. 2017;41(5):702-707.
    https://doi.org/10.1097/RCT.0000000000000588
  11. Minervini A, Raspollini MR, Tuccio A, DiCristofano C, Siena G, Salvi M, et al. Pathological Characteristics And Prognostic Effect Of Peritumoral Capsule Penetration In Renal Cell Carcinoma After Tumor Enucleation. Urologic Oncology: Seminars and Original Investigations.2014;32(50):15-22. https://doi.org/10.1016/j.urolonc.2013.07.018
  12. Ma J, Yuan E, Chen Y, Yao J, Song B. The value of radiological imaging in assessing extrarenal fat and renal vein invasion in renal cell carcinoma. Curr Med Imaging. 2024;20.
    https://doi.org/10.2174/0115734056243669231018072624
  13. Abou Elkassem AM, Lo SS, Gunn AJ, Shuch BM, Dewitt-Foy ME, Abouassaly R, et al. Role of imaging in renal cell carcinoma: A multidisciplinary perspective. Radiographics. 2021;41(5):1387-1407. https://doi.org/10.1148/rg.2021200202
  14. Hedgire SS, Elmi A, Nadkarni ND, Kai Cao, Shaunagh McDermott, Mukesh G Harisinghani. Preoperative evaluation of perinephric fat invasion in patients with renal cell carcinoma: correlation with pathological findings. Clin Imaging. 2013;37(1): 91-96.
    https://doi.org/10.1016/j.clinimag.2012.03.005
  15. Rouviere O, Brunereau L, Lyonnet D, Rouleau P. Bilan d'extension et surveillance des tumeurs malignes du rein. J Radiol 2002; 83:805-822.
  16. Gallardo E, Mendez-Vidal MJ, Perez-Gracia JL, Sepulveda-Sanchez JM, Campayo M, Chirivella-Gonzalez I, et al. SEOM clinical guideline for treatment of kidney cancer (2017). ClinTranslOncol.2018;20:47-56. https://doi.org/10.1007/s12094-017-1765-4
  17. Jeong IG, Jeong CW, Hong SK, et al. Prognostic implication of capsular invasion without perinephric fat infiltration in localized renal cell carcinoma. Urology 2006;67:709-12.
    https://doi.org/10.1016/j.urology.2005.10.042
  18. Süer E, Ergün G, Baltaci S, et al. Does renal capsular invasion have any prognostic value in localized renal cell carcinoma? J Urol 2008;180:68-71.
    https://doi.org/10.1016/j.juro.2008.03.060
  19. Yang L, Gao L, Arefan D, Tan Y, Dan H, Zhang J, et al. A CT-based radiomics model for predicting renal capsule invasion in renal cell carcinoma. BMC Med Imaging. 2022;22(1):15.
    https://doi.org/10.1186/s12880-022-00741-5
  20. Zhang Y, Zhao J, Li Z, Yang M, Ye Z. Preoperative prediction of renal fibrous capsule invasion in clear cell renal cell carcinoma using CT-based radiomics model. Br J Radiol. 2024;97(1161):1557-1567.https://doi.org/10.1093/bjr/tqae122
  21. Roy C, El Ghali S, Buy X, Lindner V, Lang H, Saussine C, et al. Significance of the pseudocapsule on MRI of renal neoplasms and its potential application for local staging: A retrospective study. AJR Am J Roentgenol. . 2005 Jan;184(1):113-20.
    https://doi.org/10.2214/ajr.184.1.01840113
  22. Gómez Pérez L, Budía Alba A, Pontones Moreno JL, Delgado Oliva FJ, Ruíz Cerdá JL, Jiménez Cruz F. Evaluation of pT3a stage in the current classification for renal cancer. Actas Urol.Esp.2006;30(3):287-294. https://doi.org/10.1016/S0210-4806(06)73441-6
  23. Kim C, Choi HJ, Cho KS. Diagnostic performance of multidetector computed tomography in the evaluation of perinephric fat invasion in renal cell carcinoma patients. J Comput Assist Tomogr2014;38(2):268-73. https://doi.org/10.1097/RCT.0b013e3182aa672a
  24. Yim K, Aron M, Rha KH, Simone G, Minervini A, Challacombe B. Outcomes of Robot-assisted Partial Nephrectomy for Clinical T3a Renal Masses: A Multicenter Analysis. Eur Urol Focus.2020;7(5):1107-1114. https://doi.org/10.1016/j.euf.2020.10.011
  25. Tian J, Zeng X, Wan J, Gan J, Ke C, Guan W, et al. Partial and radical nephrectomy provides equivalent oncologic outcomes in pT3a renal cell carcinoma: A population-based study. Front Oncol.2022;11:819098. https://doi.org/10.3389/fonc.2021.819098
  26. Fukui S, Miyake M, Iida K, Onishi K, Hori S, Morizawa Y, et al. The preoperative predictive factors for pathological T3a upstaging of clinical T1 renal cell carcinoma. Diagnostics2019,9,0076; https://doi.org/10.3390/diagnostics9030076
  27. Capitanio U, Stewart GD, Klatte T, Akdogan M, Roscigno M, Marszalek M, et al. Does the unexpected presence of non-organ-confined disease at final pathology undermine cancer control in patients with clinical T1N0M0 renal cell carcinoma who underwent partial nephrectomy?EurUrolFocus.2018;4(6):972-973. https://doi.org/10.1016/j.euf.2017.02.020
  28. Nayak JG, Patel P, Saarela O, Liu Z, Kapoor A, Finelli A, et al. Pathological upstaging of clinical T1 to pT3a renal cell carcinoma: A multi-institutional analysis of short-term outcomes. Urology.2016;94:154-160. https://doi.org/10.1016/j.urology.2016.03.029
  29. Hamilton ZA, Capitanio U, Pruthi D, Ghali F, Larcher A, Patel S, et al. Risk factors for upstaging, recurrence, and mortality in clinical T1-2 renal cell carcinoma patients upstaged to pT3a disease: An international analysis utilizing the 8th edition of the tumor-node-metastasis staging criteria. Urology. 2020 Apr:138:60-68. https://doi.org/10.1016/j.urology.2019.11.036
  30. Liu H, Kong QF, Li J, Wu YQ, Pan KH, Xu B, et al. A meta-analysis for comparison of partial nephrectomy vs. radical nephrectomy in patients with pT3a renal cell carcinoma. Transl Androl Urol. 2021;10(3):1170-1178. https://doi.org/10.21037/tau-20-1262
  31. Patel SH, Uzzo RG, Larcher A, Benoit Peyronnet, Brian R Lane, Deepak Pruthi et al. Oncologic and Functional Outcomes of Radical and Partial Nephrectomy in pT3a Pathologically Upstaged Renal Cell Carcinoma: a Multi-institutional Analysis. Clin Genitourin Cancer. 2020;18(6):e723 -e729.
    https://doi.org/10.1016/j.clgc.2020.05.002
  32. Shah, P.H.; Moreira, D.M.; Patel, V.R.; Gaunay, G.; George, A.K.; Alom, M.; Kozel, Z.; Yaskiv, O.; Hall, S.J.; Schwartz, M.J.; et al. Partial Nephrectomy is Associated with Higher Risk of Relapse Compared with Radical Nephrectomy for Clinical Stage T1 Renal Cell Carcinoma Pathologically Up Staged to T3a. J. Urol. 2017, 198, 289-296.
    https://doi.org/10.1016/j.juro.2017.03.012
  33. Bigot P, Boissier R, Khene ZE, Albiges L, Bernhard JC, Correas JM, et al. French AFU Cancer Committee Guidelines - Update 2024-2026: Management of kidney cancer. Fr J Urol. 2024;34(12):102735. https://doi.org/10.1016/j.fjurol.2024.102735
  34. Boulenger deHauteclocque A, Ferrer L, Ambrosetti D, Ricard S, Bigot P, Bensalah K, et al. Machine-learning approach for prediction of pT3a upstaging and outcomes of localized renalcell carcinoma(UroCCR-15).BJU Int. 2023;132:160-9, https://doi.org/10.1111/bju.15959
  35. Deng H, Fan Y, Yuan F, Wang L, Hong Z, Zhan J, et al. Partial nephrectomy provides equivalent oncologic outcomes and better renal function preservation than radical nephrectomy for pathological T3a renal cell carcinoma: A meta-analysis. Int Braz J Urol. 2020;47(1):46-60.
    https://doi.org/10.1590/s1677-5538.ibju.2020.0167
  36. Srivastava A, Patel HD, Joice GA, Semerjian A, Gorin MA, Johnson MH, et al. Incidence of T3a up-staging and survival after partial nephrectomy: Size-stratified rates and implications for prognosis. Urol Oncol. 2018;36(1):12.e7-12.e13. https://doi.org/10.1016/j.urolonc.2017.09.005
  37. Tan WS, Koelker M, Campain N, Cole AP, Labban M, Mossanen M. Comparison of long-term outcomes for young and healthy patients with cT1a and cT3a renal cell carcinoma treated with partial nephrectomy. Eur Urol Focus. 2023;9(2):333-335. https://doi.org/10.1016/j.euf.2022.09.018
  38. Veccia A, Falagario U, Martini A, Marchioni M, Antonelli A, Simeone C. Upstaging to pT3a in patients undergoing partial or radical nephrectomy for cT1 renal tumors: A systematic review and meta-analysis of outcomes and predictive factors. Eur Urol Focus. 2021;7(3):574-581. https://doi.org/10.1016/j.euf.2020.05.013
  39. Hansen J, Sun M, Bianchi M, J. Hansen, Maxine Sun, M. Bianchi, M. Rink, Z. Tian, N. Hanna, M. Meskawi, J. Schmitges, S. Shariat, F. Chun, P. Perrotte, M. Graefen, P. et al. Assessment of Cancer Control Outcomes in Patients With High-risk Renal Cell Carcinoma Treated With Partial Nephrectomy. Urology 2012; 80: 347-53.
    https://doi.org/10.1016/j.urology.2012.04.043
  40. Liu Z, Yang Z, Li J, Liu Z, Ma N, Chen P. Partial versus radical nephrectomy for the treatment of pT3aN0M0 renal cell carcinoma: A propensity score analysis. Asian J Surg. 2023;46(9):3607-3613. https://doi.org/10.1016/j.asjsur.2023.04.058
  41. Becker F, Roos FC, Janssen M, Brenner W, Hampel C, Siemer S, et al. Short-term functional and oncologic outcomes of nephron-sparing surgery for renal tumours ≥ 7 cm. Eur Urol. 2011;59(6):931-937. https://doi.org/10.1016/j.eururo.2011.02.017

42. Breau RH, Crispen PL, Jimenez RE, Lohse CM, Blute ML, Leibovich BC. Outcome of stage T2 or greater renal cell cancer treated with partial nephrectomy. J Urol. 2010;183(3):903-908. https://doi.org/10.1016/j.juro.2009.11.037

Statistics
Article View: 883
PDF Download: 324


Journal Management System. Powered by iJournalPro.com